What is the scope of this guideline?
This guideline addresses asymptomatic patients with SIHD that has been diagnosed solely on the basis of an abnormal screening study. This does not constitute an endorsement of such tests for the purposes of screening, and multiple ACCF/AHA guidelines and scientific statements have discouraged using ambulatory monitoring, treadmill testing, stress echocardiography, stress myocardial perfusion imaging (MPI), and computed tomography (CT) scoring of coronary calcium or coronary angiography as routine screening tests in asymptomatic individuals. This guideline does not address patients with AMI or moderate- to high-risk UA, and those with chronic stable angina or low-risk UA are addressed in the present guideline. When patients with documented IHD develop recurrent chest pain, the symptoms still could be attributable to another condition, and these patients are included in this guideline if there is sufficient suspicion that their heart disease is a likely source of symptoms to warrant cardiac evaluation.